CD4 and neoplasm: A new CXCL13+BHLHe40+ Th1‐like CD4+ subset was found to be present at higher proportion in MSI tumor and may explain higher IFN‐γ level in MSI tumor and better response of these patients to anti‐PD‐1 treatment.151, 152